Charles River Laboratories International, Inc.

CRLNYSE • USD
313.96 USD
↗ 3.19 (1.03%)🟢PRE MARKET (AS OF 09:28 AM EDT)
🟢Market: OPEN

Shares of Charles River Laboratories International, Inc. (CRL) are trading at $313.96. Technicals currently rate "Strong Buy" while our fundamental analysis reads "Neutral". Notable factors include a robust Altman Z-Score, negative Return on Equity, a bullish Golden Cross on the moving averages and bullish moving average alignment. Valuation metrics place CRL at a fair price relative to peers.

Technical & fundamental data as of Oct 5, 2026.

Open?$312.15
High?$314.01
Low?$312.15
Prev. Close?$310.77
Volume?7.1K
Avg. Volume?934.0K
VWAP?$313.71
Rel. Volume?0.01x
Bid / Ask
Bid?$313.00 × 500
Ask?$314.00 × 100
Spread?$1.00
Midpoint?$313.50
Valuation & Ratios
Market Cap?14.8B
Shares Out?47.7M
Float?47.1M
Float %?98.8%
P/E Ratio?N/A
P/B Ratio?5.22
EPS?-$5.00
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provide in vitro (nonanimal) testing products, biologics testing services, and avian vaccine services.
Employees
19.7K
Market Cap
14.8B
Industry
SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Listed
2000-06-23
Address
251 BALLARDVALE ST
WILMINGTON, MA 01887
Phone: 781-222-6000
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+3/3)
Medium-Term (Wave)?▲ Bullish(+3/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Golden Alignment
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
23
Z-Score?
95
Momentum?
57
Short Sent.?
60
Piotroski F-Score?3/9Weak
Altman Z-Score?4.37Safe
Confidence?61%Moderate
Full Fundamental Analysis →
Short InterestLow
Short % of Float?4.73%Low
Short Interest?2.2M
Days to Cover?2.8
Free Float47.1M
Avg Daily Volume811.7K
Settlement Date2026-09-15
Financial Health
Current Ratio?1.35Adequate
Quick Ratio?1.04Adequate
Cash Ratio?0.17Low
Debt/Equity?0.92Moderate
ValuationFAIRLY VALUEDvs 6 peers + S&P 500
Score
53/100
P/E?
N/A▾
P/B?
Peers
71
S&P
35
5.22FAIR▾
P/S?
Peers
86
S&P
41
3.71FAIR▾
P/FCF?
Peers
29
S&P
17
40.0PRICEY▾
EV/EBITDA?
Peers
86
S&P
19
22.6HIGH▾
EV/Sales?
Peers
71
S&P
43
4.32FAIR▾
Returns & Efficiency
ROE?
Peers
14
S&P
10
-8.4%WEAK▾
ROA?
Peers
14
S&P
3
-3.2%WEAK▾
Cash Flow & Enterprise
FCF?$370.6M
Enterprise Value?$17.3B
Fundamentals ratios updated end of day